false
Catalog
Clinical Management of Perinatal Mental and Substa ...
View Presentation
View Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This four-part webinar series focuses on perinatal mental and substance use disorders and is a collaborative effort funded by the CDC. The webinars discuss the importance of addressing these disorders due to their impact on obstetrical outcomes and the well-being of mothers and infants. The series aims to enhance awareness, understand treatment and training gaps, and provide recommendations. Topics covered include epidemiology, clinical management, vulnerable populations, and education and training.<br /><br />The second part of the webinar series focuses on clinical management and discusses the safety and risks of various medications used during pregnancy and lactation. Key points include:<br />- Antidepressant exposure does not appear to be linked to childhood autism.<br />- The impact of antidepressants on fetal growth and timing of delivery is mixed.<br />- SSRI use in pregnancy may be associated with a small increase in the risk of persistent pulmonary hypertension of the newborn.<br />- The safety and risks of different classes of antidepressants, mood stabilizers, and antipsychotics vary.<br />- Medication-assisted treatment is recommended for pregnant individuals with opioid use disorder.<br />- The safety of alcohol use disorder medications and smoking cessation medications during pregnancy and lactation is still being studied.<br />- Psychotherapy, support groups, and alternative treatments can also be effective in managing perinatal mental health and substance use disorders.<br /><br />It is important for clinicians to stay informed on current studies and provide individualized treatment plans based on a risk-benefit analysis.<br /><br />Summary written by [Your Name]
Keywords
perinatal mental disorders
substance use disorders
webinar series
CDC
obstetrical outcomes
mothers
infants
clinical management
medications
pregnancy
lactation
opioid use disorder
risk-benefit analysis
×
Please select your language
1
English